Liu ZP - Search Results

1

Recent developments of small molecule EGFR inhibitors based on the quinazoline core scaffolds.

Yu-Jing YJ, Zhang CM, Liu ZP. Yu-Jing YJ, et al. Among authors: liu zp. Anticancer Agents Med Chem. 2012 May;12(4):391-406. doi: 10.2174/187152012800228652. Anticancer Agents Med Chem. 2012. PMID: 22043991 Review.

2

Synthesis and evaluation of trehalose-based compounds as anti-invasive agents.

Jiang YL, Tang LQ, Miyanaga S, Igarashi Y, Saiki I, Liu ZP. Jiang YL, et al. Among authors: liu zp. Bioorg Med Chem Lett. 2011 Feb 15;21(4):1089-91. doi: 10.1016/j.bmcl.2010.12.133. Epub 2011 Jan 4. Bioorg Med Chem Lett. 2011. PMID: 21269828

3

Design and synthesis of potent HIV-1 protease inhibitors incorporating hydroxyprolinamides as novel P2 ligands.

Gao BL, Zhang CM, Yin YZ, Tang LQ, Liu ZP. Gao BL, et al. Among authors: liu zp. Bioorg Med Chem Lett. 2011 Jun 15;21(12):3730-3. doi: 10.1016/j.bmcl.2011.04.070. Epub 2011 Apr 24. Bioorg Med Chem Lett. 2011. PMID: 21555220

4

Syntheses of 2,3-diarylated 2H-benzo[e][1,2]thiazine 1,1-dioxides and their 3,4-dihydro derivatives, and assessment of their inhibitory activity against MCF-7 breast cancer cells.

Shan YY, Zhang CM, Tang LQ, Liu ZP, Bearss NR, Sarver JG, Luniwal A, Erhardt PW. Shan YY, et al. Among authors: liu zp. Med Chem. 2011 Nov;7(6):561-71. doi: 10.2174/157340611797928307. Med Chem. 2011. PMID: 22313296

5

Recent developments of p38α MAP kinase inhibitors as antiinflammatory agents based on the imidazole scaffolds.

Kong TT, Zhang CM, Liu ZP. Kong TT, et al. Among authors: liu zp. Curr Med Chem. 2013;20(15):1997-2016. doi: 10.2174/0929867311320150006. Curr Med Chem. 2013. PMID: 23317165 Review.

6

Recent developments of 2-substituted analogs of 1,25(OH)(2)D(3).

Zhang CF, Liu ZP. Zhang CF, et al. Among authors: liu zp. Curr Med Chem. 2013;20(16):2080-95. doi: 10.2174/0929867311320160003. Curr Med Chem. 2013. PMID: 23514414 Review.

7

Preparation of S14161 and its analogues and the discovery of 6-bromo-8-ethoxy-3-nitro-2H-chromene as a more potent antitumor agent in vitro.

Yin SQ, Shi M, Kong TT, Zhang CM, Han K, Cao B, Zhang Z, Du X, Tang LQ, Mao X, Liu ZP. Yin SQ, et al. Among authors: liu zp. Bioorg Med Chem Lett. 2013 Jun 1;23(11):3314-9. doi: 10.1016/j.bmcl.2013.03.097. Epub 2013 Apr 4. Bioorg Med Chem Lett. 2013. PMID: 23601711

8

Recent developments of 19-nor-1,25-dihydroxyvitamin D3 analogues.

Zhang CF, Wan RZ, Liu ZP. Zhang CF, et al. Among authors: liu zp. ChemMedChem. 2013 Aug;8(8):1249-60. doi: 10.1002/cmdc.201300160. Epub 2013 Jun 20. ChemMedChem. 2013. PMID: 23788554 Review.

9

Recent developments of small molecule PI3K/mTOR dual inhibitors.

Liu YN, Wan RZ, Liu ZP. Liu YN, et al. Among authors: liu zp. Mini Rev Med Chem. 2013 Dec;13(14):2047-59. doi: 10.2174/13895575113136660105. Mini Rev Med Chem. 2013. PMID: 24195664 Review.

10

Developments of kinesin spindle protein inhibitors as antitumor agents based on the five-membered heterocycle scaffolds.

Zhao GD, Wan RZ, Liu ZP. Zhao GD, et al. Among authors: liu zp. Curr Med Chem. 2014;21(23):2691-701. doi: 10.2174/0929867321666140304110609. Curr Med Chem. 2014. PMID: 24606497 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

768 results

Search Page

Filters